RxMP Therapeutics

RxMP Therapeutics is a pharmaceutical company focused on developing patented drugs for the treatment of excessive bleeding. Their goal is to develop and commercialize RMP-HPE (red blood cell-derived microparticles produced by high-pressure extrusion) as a new hemostatic agent for the treatment or prevention of excessive bleeding.